Haemonetics Corporation (HAE) Balance Sheet
HAE balance sheet, FY2026
March 31, 2026 · U.S. dollars$2.40B assets = $1.60B liabilities + $796.3M equity
Both columns are drawn to the same scale: what HAE owns equals what it owes plus shareholders’ equity. Hover a block for its value.
HAE financial health
Current ratio2.95
Comfortable · current assets cover current liabilities 2.95×
Debt / equity1.54
High leverage · $1.54 of debt for each $1 of equity
Equity / assets33.2%
Balanced · of assets funded by shareholders
Cash / debt20.0%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles46.1%
Acquisition-heavy · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
HAE balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.24BFY2017 | $2.40BFY2026 | +7.6%/yr | |
| Total liabilities | $499.1MFY2017 | $1.60BFY2026 | +13.8%/yr | |
| Shareholders’ equity | $739.6MFY2017 | $796.3MFY2026 | +0.8%/yr | |
| Cash & short-term investments | $139.6MFY2017 | $245.4MFY2026 | +6.5%/yr | |
| Total debt | $314.6MFY2017 | $1.22BFY2026 | +16.3%/yr | |
| Net cash (debt) | −$175.1MFY2017 | −$979.1MFY2026 | −$804.1M | |
| Working capital | $298.9MFY2017 | $552.3MFY2026 | +$253.4M | |
| Book value per share | $14.35FY2017 | $16.82FY2026 | +1.8%/yr | |
| Current ratio | 2.42FY2017 | 2.95FY2026 | +0.54 | |
| Debt / equity | 0.43FY2017 | 1.54FY2026 | +1.11 | |
| Shares outstanding | 51.5MFY2017 | 47.4MFY2026 | −0.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
HAE assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
HAE liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
HAE debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
HAE balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M | $192.3M | $137.3M | $169.4M | $180.2M | $139.6M |
| Cash & equivalents | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M | $192.3M | $137.3M | $169.4M | $180.2M | $139.6M |
| Short-term investments | — | — | $1.7M | $1.1M | — | — | — | — | $0 | $64,000 |
| Receivables | $216.9M | $202.7M | $206.6M | $179.1M | $159.4M | $127.6M | $165.2M | $185.0M | $151.2M | $152.7M |
| Inventory | $306.4M | $365.1M | $317.2M | $259.4M | $293.0M | $322.6M | $270.3M | $194.3M | $160.8M | $176.9M |
| Other current assets | $66.2M | $60.4M | $66.3M | $46.7M | $44.1M | $51.1M | $30.8M | $27.4M | $29.0M | $40.9M |
| Total current assets | $834.9M | $935.0M | $768.9M | $769.7M | $756.0M | $693.5M | $603.6M | $576.1M | $521.2M | $510.0M |
| Property, plant & equipment (net) | $305.8M | $284.1M | $366.6M | $310.9M | $258.5M | $217.6M | $253.4M | $344.0M | $332.2M | $323.9M |
| Goodwill & intangible assets | $1.10B | $1.06B | $971.2M | $742.0M | $777.5M | $831.9M | $343.8M | $338.5M | $368.0M | $388.4M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $151.3M | $171.9M | $88.9M | $112.2M | $67.7M | $76.9M | $66.3M | $16.2M | $16.0M | $16.4M |
| Total assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B |
| Liabilities | ||||||||||
| Accounts payable | $51.1M | $67.0M | $73.4M | $63.9M | $58.4M | $50.3M | $50.7M | $63.4M | $55.3M | $43.0M |
| Short-term debt | $5.0M | $303.6M | $10.2M | $11.8M | $221.3M | $24.7M | $84.3M | $27.7M | $194.3M | $61.0M |
| Deferred revenue | $42.3M | $43.3M | $31.2M | $30.2M | $26.8M | $26.3M | $28.8M | $27.3M | $25.8M | $26.5M |
| Total current liabilities | $282.6M | $578.1M | $300.4M | $251.8M | $442.3M | $253.5M | $274.8M | $235.8M | $384.7M | $211.2M |
| Long-term debt | $1.22B | $921.2M | $797.6M | $754.1M | $559.4M | $690.6M | $305.5M | $322.5M | $59.4M | $253.6M |
| Lease obligations | — | — | — | — | $7.2M | $70.7M | $59.3M | — | — | — |
| Other long-term liabilities | $97.4M | $130.8M | $137.7M | $110.9M | $108.6M | $144.2M | $99.7M | $48.7M | $40.8M | $34.3M |
| Total liabilities | $1.60B | $1.63B | $1.24B | $1.12B | $1.11B | $1.09B | $680.0M | $606.9M | $484.9M | $499.1M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $453,000 | $482,000 | $508,000 | $504,000 | $511,000 | $509,000 | $503,000 | $510,000 | $523,000 | $523,000 |
| Retained earnings (deficit) | $279.3M | $352.2M | $360.5M | $253.2M | $202.4M | $158.0M | $78.5M | $161.4M | $266.9M | $289.9M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$37.6M | −$55.1M | −$35.6M | −$30.4M | −$26.0M | −$29.5M | −$45.1M | −$30.4M | −$19.0M | −$32.9M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $796.3M | $820.8M | $960.0M | $818.0M | $749.4M | $731.7M | $587.1M | $667.9M | $752.4M | $739.6M |
| Key figures | ||||||||||
| Total debt | $1.22B | $1.22B | $807.8M | $765.9M | $780.8M | $778.3M | $441.8M | $350.1M | $253.7M | $314.6M |
| Net cash (debt) | −$979.1M | −$918.0M | −$629.0M | −$481.4M | −$521.3M | −$586.0M | −$304.5M | −$180.8M | −$73.5M | −$175.1M |
| Working capital | $552.3M | $356.9M | $468.5M | $517.9M | $313.8M | $440.1M | $328.8M | $340.4M | $136.5M | $298.9M |
| Tangible book value | −$307.7M | −$239.2M | −$11.2M | $76.0M | −$28.1M | −$100.3M | $243.4M | $329.4M | $384.4M | $351.2M |
| Book value per share | $16.82 | $16.18 | $18.68 | $15.91 | $14.59 | $14.26 | $11.33 | $12.62 | $14.06 | $14.35 |
| Shares outstanding | 47.4M | 50.7M | 51.4M | 51.4M | 51.4M | 51.3M | 51.8M | 52.9M | 53.5M | 51.5M |
| Current ratio | 2.95 | 1.62 | 2.56 | 3.06 | 1.71 | 2.74 | 2.20 | 2.44 | 1.35 | 2.42 |
| Quick ratio | 1.64 | 0.88 | 1.28 | 1.84 | 0.95 | 1.26 | 1.10 | 1.50 | 0.86 | 1.38 |
| Debt / equity | 1.54 | 1.49 | 0.84 | 0.94 | 1.04 | 1.06 | 0.75 | 0.52 | 0.34 | 0.43 |
| Equity / assets | 33.2% | 33.5% | 43.7% | 42.3% | 40.3% | 40.2% | 46.3% | 52.4% | 60.8% | 59.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $223.4M | $245.4M | $363.4M | $296.4M | $292.9M | $306.8M | $320.8M | $299.3M | $344.4M | $178.8M | $194.0M | $351.0M |
| Cash & equivalents | $223.4M | $245.4M | $363.4M | $296.4M | $292.9M | $306.8M | $320.8M | $299.3M | $344.4M | $178.8M | $194.0M | $351.0M |
| Short-term investments | — | — | — | — | — | — | — | — | $1.6M | $1.7M | $1.1M | $2.6M |
| Receivables | $216.1M | $216.9M | $195.7M | $207.1M | $200.8M | $202.7M | $211.9M | $213.5M | $201.5M | $206.6M | $211.6M | $174.2M |
| Inventory | $306.7M | $306.4M | $321.2M | $336.2M | $360.5M | $365.1M | $359.6M | $382.1M | $373.8M | $317.2M | $304.0M | $285.8M |
| Other current assets | $64.6M | $66.2M | $63.4M | $60.0M | $59.0M | $60.4M | $113.5M | $61.0M | $58.9M | $66.3M | $55.4M | $54.7M |
| Total current assets | $810.8M | $834.9M | $943.7M | $899.7M | $913.2M | $935.0M | $1.01B | $955.9M | $978.6M | $768.9M | $765.0M | $865.7M |
| Property, plant & equipment (net) | $303.8M | $305.8M | $297.2M | $292.5M | $286.9M | $284.1M | $286.1M | $300.5M | $302.5M | $311.4M | $318.7M | $307.8M |
| Goodwill & intangible assets | $1.09B | $1.10B | $1.03B | $1.03B | $1.06B | $1.06B | $1.07B | $1.10B | $1.11B | $971.2M | $984.3M | $715.9M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $159.4M | $151.3M | $223.4M | $215.5M | $204.1M | $171.9M | $168.4M | $164.8M | $151.6M | $144.1M | $132.5M | $121.9M |
| Total assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B |
| Liabilities | ||||||||||||
| Accounts payable | $56.3M | $51.1M | $48.7M | $61.7M | $46.0M | $67.0M | $63.0M | $69.2M | $76.9M | $73.4M | $56.8M | $80.2M |
| Short-term debt | $5.0M | $5.0M | $304.7M | $304.3M | $303.9M | $303.6M | $5.1M | $5.4M | $5.1M | $10.2M | $13.7M | $13.6M |
| Deferred revenue | — | $42.3M | — | — | $49.2M | $43.3M | $35.6M | $36.7M | $33.6M | $31.2M | $58.8M | −$80.2M |
| Total current liabilities | $263.2M | $282.6M | $539.9M | $548.3M | $531.4M | $578.1M | $253.2M | $273.9M | $260.1M | $300.4M | $261.8M | $264.2M |
| Long-term debt | $1.17B | $1.22B | $920.0M | $920.4M | $920.8M | $921.2M | $1.22B | $1.22B | $1.22B | $797.6M | $856.8M | $748.7M |
| Other long-term liabilities | $95.9M | $97.4M | $119.6M | $124.3M | $127.6M | $130.8M | $151.4M | $152.9M | $157.1M | $137.7M | $138.5M | $104.7M |
| Total liabilities | $1.53B | $1.60B | $1.58B | $1.59B | $1.58B | $1.63B | $1.62B | $1.65B | $1.64B | $1.24B | $1.26B | $1.12B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $455,000 | $453,000 | $468,000 | $467,000 | $482,000 | $482,000 | $502,000 | $504,000 | $512,000 | $508,000 | $508,000 | $507,000 |
| Retained earnings (deficit) | $311.5M | $279.3M | $381.1M | $336.3M | $356.0M | $352.2M | $392.2M | $368.5M | $386.6M | $360.5M | $340.1M | $308.9M |
| Accumulated other comprehensive income | −$41.6M | −$37.6M | −$34.6M | −$40.5M | −$36.2M | −$55.1M | −$55.5M | −$34.6M | −$42.7M | −$35.6M | −$24.4M | −$32.7M |
| Total shareholders' equity | $837.1M | $796.3M | $911.5M | $849.2M | $882.3M | $820.8M | $906.9M | $878.9M | $905.4M | $960.0M | $943.3M | $893.7M |
| Key figures | ||||||||||||
| Total debt | $1.17B | $1.22B | $1.22B | $1.22B | $1.22B | $1.22B | $1.22B | $1.22B | $1.22B | $807.8M | $870.6M | $762.2M |
| Net cash (debt) | −$950.8M | −$979.1M | −$861.4M | −$928.3M | −$931.9M | −$918.0M | −$904.0M | −$925.7M | −$879.2M | −$629.0M | −$676.6M | −$411.2M |
| Working capital | $547.6M | $552.3M | $403.8M | $351.4M | $381.8M | $356.9M | $752.6M | $682.0M | $718.5M | $468.5M | $503.2M | $601.5M |
| Tangible book value | −$254.3M | −$307.7M | −$115.1M | −$185.3M | −$175.6M | −$239.2M | −$164.0M | −$225.1M | −$202.9M | −$11.2M | −$41.0M | $177.8M |
| Book value per share | $18.32 | $17.23 | $19.40 | $17.82 | $18.25 | $16.59 | $17.91 | $17.15 | $17.56 | $18.67 | $18.34 | $17.39 |
| Shares outstanding | 45.7M | 46.2M | 47.0M | 47.7M | 48.4M | 49.5M | 50.6M | 51.2M | 51.6M | 51.4M | 51.4M | 51.4M |
| Current ratio | 3.08 | 2.95 | 1.75 | 1.64 | 1.72 | 1.62 | 3.97 | 3.49 | 3.76 | 2.56 | 2.92 | 3.28 |
| Quick ratio | 1.67 | 1.64 | 1.04 | 0.92 | 0.93 | 0.88 | 2.10 | 1.87 | 2.10 | 1.28 | 1.55 | 1.99 |
| Debt / equity | 1.40 | 1.54 | 1.34 | 1.44 | 1.39 | 1.49 | 1.35 | 1.39 | 1.35 | 0.84 | 0.92 | 0.85 |
| Equity / assets | 35.4% | 33.2% | 36.6% | 34.8% | 35.8% | 33.5% | 35.8% | 34.8% | 35.6% | 43.7% | 42.9% | 44.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed May 20, 2026); data from EODHD.
HAE financial position
At the end of fiscal 2026 (March 31, 2026), Haemonetics had total assets of $2.4 billion (down 2.2% from a year earlier), total liabilities of $1.6 billion and shareholders' equity of $796.3 million. It held $245.4 million in cash and short-term investments against $1.2 billion of debt, net debt of $979.1 million. Its current ratio was 2.95. In the latest quarter (ended June 30, 2026) total assets were $2.4 billion and equity $837.1 million.
Related: HAE income statement, HAE cash flow statement, HAE key metrics. See the HAE stock overview for the latest quote and news.
HAE balance sheet FAQ
What are Haemonetics's total assets?
Haemonetics reported total assets of $2.4 billion at the end of fiscal 2026 (March 31, 2026), compared with $2.5 billion a year earlier.
How much debt does Haemonetics have?
Haemonetics had $1.2 billion of total debt at the end of fiscal 2026, including short-term borrowings. Its debt-to-equity ratio was 1.54.
How much cash does Haemonetics have?
Haemonetics held $245.4 million in cash and short-term investments at the end of fiscal 2026; with $1.2 billion of debt that is net debt of $979.1 million.
What is Haemonetics's book value?
Haemonetics's shareholders' equity (book value) was $796.3 million at the end of fiscal 2026, or $16.82 per share.
What is Haemonetics's current ratio?
Haemonetics had current assets of $834.9 million and current liabilities of $282.6 million, a current ratio of 2.95 (it can cover its short-term obligations).
How much goodwill does Haemonetics have?
Haemonetics carried $1.1 billion of goodwill and intangible assets, 46.1% of total assets, at the end of fiscal 2026.